ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000800.1|Xanthan_1 # 33 # 332 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.600	BGC0000800.1|Xanthan_1 	33	332	+	Loose	500	28.4906	sul4	33.33	3004361	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGGCATTGACGAAAGCGGAGATGGCCGAGCGTCTGTTCGACGAAGTCGGCCTGAACAAGCGTGAGGCGAAGGAATTCGTCGACGCGTTTTTCGATGTGCTGCGCGATGCACTGGAGCAGGGCCGTCAGGTGAAGTTGTCGGGCTTCGGCAACTTCGATCTGCGGCGCAAGAACCAACGGCCCGGTCGCAATCCCAAGACCGGTGAGGAAATTCCGATCTCGGCCAGGACGGTGGTGACCTTCCGCCCCGGCCAGAAACTCAAGGAACGGGTGGAGGCTTATGCTGGATCCGGGCAGTAA	MALTKAEMAERLFDEVGLNKREAKEFVDAFFDVLRDALEQGRQVKLSGFGNFDLRRKNQRPGRNPKTGEEIPISARTVVTFRPGQKLKERVEAYAGSGQ	MSTTLTSFKWGERTYIMGILNVTPDSFSGDGVMVEEDVIAKAVAQAKQFVADGADIIDIGGESTRPGSSPISAEEELARVLPVVQAVRQAVDVVISIDSYRASVAEAALAAGASWLNDVWGLRMDPDMAGLAAQAGCPIVLMHNRSKPKNIAQEKKLGGRFIGVKYDDLITDVKRELQESIDIALKAGVKESQIILDPGIGFGKTVEQSLQLLDQINQFKTMGFPILIGPSRKSFIGYTLDLPPDQRIEGTAATVAIGIDRGADVVRVHDVKAIVRVARMTDAIVRR	34.49	gnl|BL_ORD_ID|2548|hsp_num:0	2875		
BGC0000800.1|Xanthan_2 # 313 # 669 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.616	BGC0000800.1|Xanthan_2 	313	669	+	Loose	275	25.0238	AAC(6')-IIb	42.31	3002595	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCTGGATCCGGGCAGTAATCGCGAGCTACCGCCGATTCCGGCCAAGCGCTACTTCACCATCGGTGAGGTGAGCGAGCTGTGCGACGTCAAGCCGCACGTGCTGCGCTATTGGGAAACCGAATTTCCGAGCCTGGAGGCCAGTCAAGCGGCGCGCAACCGACGCTACTACCAGCGGCACGATGTCGTGATGGTGCGGCAGATTCGTGGCCTGCTGTACGAGCAGGGTTACACCATCGGGGGCGCGCGTCTGCGTCTTGAAGGGGATGGGGCCAAGAGCGAGTCAGCGCTGAGCAATCAGATCATCAAGCAGGTGCGCATGGAGCTTGAAGAAGTCCTGCAGCTGCTGCGACGCTAG	MLDPGSNRELPPIPAKRYFTIGEVSELCDVKPHVLRYWETEFPSLEASQAARNRRYYQRHDVVMVRQIRGLLYEQGYTIGGARLRLEGDGAKSESALSNQIIKQVRMELEEVLQLLRR	MHPGVVTLRPMTEDDIGMLHEWLNRPHIVEWWGGERPSLEEVKEDYRPSALAEEGVTPYIGLLDGTPFAFAQSYVALGSGGGWWEEETDPGVRGIDQSIADSGLLGRGYGTRLVQALVDLLFADPQVSKVQTDPSPNNMRAIRCYEKAGFRKVKVVSTPDGPAMYMLHERPLVNGLRSAA	65.56	gnl|BL_ORD_ID|125|hsp_num:0	140		
BGC0000800.1|Xanthan_3 # 1403 # 1975 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.616	BGC0000800.1|Xanthan_3 	1403	1975	+	Loose	650	24.6386	mexM	35.14	3003704	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCACGGTGCAGCCCGAATACCGTCTTGCGCCGGGCGATCTGTTGCTGGTGAAGGTGTTTCAGATCGACGATCTGGAGCGGCAGGTCCGCATCGACCAGAACGGTCACATCTCACTGCCGTTGATTGGCGACGTCAAGGCCGCCGGTCTGGGCGTTGGCGAACTGGAAAAGCTGGTCGCCGATCGGTATCGCGCAGGCTACCTGCAGCAGCCGCAGATTTCGGTATTCGTGCAGGAGTCCAACGGGCGTCGCGTCACGGTCACTGGTGCGGTAGACGAGCCGGGCATCTACCCGGTGATCGGCGCCAACCTCACCTTGCAGCAGGCGATCGCGCAGGCCAAGGGTGTCAGCACGGTGGCAAGCCGCGGCAACGTGATCGTGTTCCGCATGGTCAACGGGCAAAAAATGATTGCGCGGTTCGACCTGACCGAGATCGAGAAGGGGGCCAATCCGGATCCTGAGATTTATGGCGGCGACATTGTCGTGGTGTATCGCTCGGATGCGCGCGTGTGGTTGCGCACCATGCTGGAACTGACCCCCTTGGTGATGGTGTGGCGCGCTTACCGATGA	MSTVQPEYRLAPGDLLLVKVFQIDDLERQVRIDQNGHISLPLIGDVKAAGLGVGELEKLVADRYRAGYLQQPQISVFVQESNGRRVTVTGAVDEPGIYPVIGANLTLQQAIAQAKGVSTVASRGNVIVFRMVNGQKMIARFDLTEIEKGANPDPEIYGGDIVVVYRSDARVWLRTMLELTPLVMVWRAYR	MQALRSGGGRVLVGVLAAGLVAFGGWAWLGGDAGAKAAPAPARVPVIVARVERRDVEQQVSGIGTVTSLHNVVIRTQIDGQLTRLLVSEGQMVEAGELLATIDDRAVVAALEQAQASRASNQAQLKSAEQDLQRYRSLYAERAVSRQLLDQQQATVDQLRATLKANDATINAERVRLSYTRITSPVSGKVGIRNVDVGNLVRVGDSLGLFSVTQIAPISVVFSLQQEQLLQLQALLGGEAAVRAYSRDGGSALGEGRLLTIDNQIDSSTGTIRVRASFDNRQARLWPGQFVAVSLHTGVRRDQLVLSSKAVRRGLEGNFVYRVADDRVEAVPVRVLQDIDGLSVVEGLASGDQVVVDGHSRLMPGALVDIQEPRPSLAQATERRP	49.35	gnl|BL_ORD_ID|2065|hsp_num:0	2216		
BGC0000800.1|Xanthan_4 # 2048 # 3397 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.606	BGC0000800.1|Xanthan_4 	2048	3397	+	Loose	620	28.1054	ROB-3	42.22	3005073	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ROB beta-lactamase	ATGGACTACTGGCGCGCCCTGGTCTCGCAGCTCTGGCTGATCATCCTGATCGCCGTCGGCGCGCTGTTGCTGGCATTCGGCATCACGATGTTGATGCCCGAGAAGTACCGCGCCACCAGCACCCTGCAGATCGAACGTGACTCGCTCAATGTGGTGAACGTCGACAACCTGATGCCGGTGGAATCGCCGCAGGATCGCGATTTCTACCAGACCCAGTACCAGTTGCTGCAGAGCCGTTCGCTGGCGCGTGCGGTGATCCGGGAAGCCAAGCTCGATCAGGAGCCGGCGTTCAAGGAGCAGGTGGAGGAGGCGCTGGCCAAAGCCGCCGAAAAGAATCCCGAGGCGGGTAAGTCGCTCGATTCGCGGCAGGCGATCGTCGAGCGCAGCCTCACCGATACGTTGCTCGCCGGGCTGGTGGTCGAGCCGATCCTCAACTCGCGCCTGGTGTACGTCAATTACGATTCGCCAGACCCGGTGCTGGCCGCCAAGATCGCCAATACGTACCCGAAGGTGTTCATCGTCAGCACCCAGGAACGCCGCATGAAGGCGTCTTCGTTTGCGACACAGTTTCTGGCTGAGCGCCTGAAGCAGTTGCGCGAGAAGGTCGAAGACTCTGAAAAGGATCTGGTCTCGTATTCGACCGAAGAGCAGATCGTGTCGGTTGGCGATGACAAGCCCTCGCTGCCTGCGCAGAATCTGACCGATCTCAATGCGTTGCTGGCATCCGCACAGGACGCCCGGATCAAGGCCGAGTCAGCTTGGCGGCAGGCTTCCAGTGGCGATGGCATGTCATTGCCGCAGGTGTTGAGCAGCCCGCTGATTCAAAGCCTGCGCAGCGAGCAGGTGCGTCTGACCAGCGAGTACCAGCAGAAACTGTCGACCTTCAAGCCGGATTACCCGGAGATGCAGCGCCTCAAGGCGCAGATCGAAGAGTCGCGTCGTCAGATCAATGGCGAAGTCATCAATATCCGTCAGTCGCTGAAGGCGACCTACGACGCCTCCGTGCATCAGGAGCAGCTGCTCAACGACCGCATCGCCGGTCTGCGGTCCAACGAGCTGGATCTGCAGAGCCGCAGCATCCGCTACAACATGCTCAAGCGCGACGTCGACACCAACCGCCAGCTCTACGATGCGCTCCTGCAGCGCTACAAGGAAATCGGCGTGGCGAGCAACGTGGGCGCCAACAACGTGACCATCGTCGATACCGCAGACGTGCCTACGTCTAAGACTTCGCCGAAACTCAAATTGAACCTCGCGTTGGGCCTGATCTTTGGCGTATTCCTGGGCGTGGCTGTGGCTCTGGTTCGCTACTTCCTGCGTGGGCCTTCTCCGAGGTCGCGGTTGAACTGA	MDYWRALVSQLWLIILIAVGALLLAFGITMLMPEKYRATSTLQIERDSLNVVNVDNLMPVESPQDRDFYQTQYQLLQSRSLARAVIREAKLDQEPAFKEQVEEALAKAAEKNPEAGKSLDSRQAIVERSLTDTLLAGLVVEPILNSRLVYVNYDSPDPVLAAKIANTYPKVFIVSTQERRMKASSFATQFLAERLKQLREKVEDSEKDLVSYSTEEQIVSVGDDKPSLPAQNLTDLNALLASAQDARIKAESAWRQASSGDGMSLPQVLSSPLIQSLRSEQVRLTSEYQQKLSTFKPDYPEMQRLKAQIEESRRQINGEVINIRQSLKATYDASVHQEQLLNDRIAGLRSNELDLQSRSIRYNMLKRDVDTNRQLYDALLQRYKEIGVASNVGANNVTIVDTADVPTSKTSPKLKLNLALGLIFGVFLGVAVALVRYFLRGPSPRSRLN	MLNKLKIGTLLLLTLTLTACSPNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQARIGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYSPETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHANRLEPDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATPTSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFHTLQLN	146.25	gnl|BL_ORD_ID|2838|hsp_num:0	3809		
BGC0000800.1|Xanthan_5 # 3640 # 5094 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.617	BGC0000800.1|Xanthan_5 	3640	5094	+	Loose	750	25.7942	tetX	32.14	3000205	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGCTTTTGGCAGACTTGAGTAGCGCGACTTACACGACATCCTCGCCGCGATTGTTGTCCAAATATTCGGCAGCCGCCGACCTGGTCCTGCGCGTGTTCGACCTGACCATGGTCGTTGCGTCCGGACTGATCGCATACCGCATCGTTTTCGGTACCTGGGTACCCGCAGCGCCTTATCGGGTCGCGATTGCGACAACGTTGTTGTACTCGGTGATCTGCTTTGCGTTGTTCCCGCTGTATCGCAGCTGGCGCGGCCGTGGATTGCTGAGTGAGCTGGTGGTGCTGGGTGGCGCATTCGGCGGTGTGTTTGCGCTGTTCGCGGTGCATGCCCTGATCGTGCAGGTGGGTGAGCAGGTGTCGCGTGGTTGGGTCGGCCTGTGGTTCGTCGGCGGCCTGGTGTCGCTGGTGGCCGCACGCACCTTGCTGCGTGGCTTCCTCAATCACCTGCGCACGCAGGGCGTGGATGTCCAGCGTGTGGTGGTAGTGGGCCTGCGTCATCCGGTGATGAAGATCAGTCATTACCTGAGCCGTAATCCCTGGGTCGGCATGAACATGGTTGGCTATTTCCGCACGCCGTACGATCTGGCGGTGGCCGAACAGCGCCAGGGTCTGCCGTGCCTGGGTGATCCCGATGAGCTGATCGAGTACCTGAAGAACAACCAGGTGGAGCAGGTGTGGATCTCGCTGCCGCTTGGCGAGCGCGACCACATCAAGCAGCTGCTGCAGCGCCTGGATCGCTACCCGATCAACGTGAAGCTGGTGCCCGACCTGTTCGACTTCGGCCTGTTGAACCAGTCTGCCGAGCAGATCGGCAGCGTGCCGGTGATCAACCTGCGTCAGGGTGGCGTGGATCGTGACAACTACTTCGTGGTCGCCAAGGCGCTGCAGGACAAGATCCTGGCGGTGATTGCGCTGATGGGCCTGTGGCCGCTGATGCTGGCCATTGCGGTAGGCGTGAAGATGAGCTCGCCCGGCCCGGTGTTCTTCCGTCAGCGCCGCCACGGCCTGGGTGGCCGCGAGTTCTACATGTTCAAGTTCCGCTCGATGCGGGTGCATGACGATCATGGCACCACGATTCAGCAGGCGACCAAGAACGACACGCGGATTACGCGCTTCGGCAGTTTCCTGCGCCGCAGCAGCCTGGACGAGCTGCCGCAGATCTTCAATGTCTTGGGTGGCAGCATGTCGATCGTGGGCCCGCGCCCGCACGCCGCGCAGCACAACACGCACTATGAAAAGCTGATCAACCATTACATGCAGCGTCACTACGTCAAGCCGGGGATTACCGGTTGGGCGCAGGTCAACGGTTTCCGCGGTGAGACCCCGGAGCTGCGGACGATGAAGAAGCGCATCCAGTACGACCTTGACTACATCCGTCGTTGGTCGCTGTGGCTGGATATCCGCATCATCGTGCTGACGGCCGTGCGCGTGCTCGGACAGAAGACCGCGTACTGA	MLLADLSSATYTTSSPRLLSKYSAAADLVLRVFDLTMVVASGLIAYRIVFGTWVPAAPYRVAIATTLLYSVICFALFPLYRSWRGRGLLSELVVLGGAFGGVFALFAVHALIVQVGEQVSRGWVGLWFVGGLVSLVAARTLLRGFLNHLRTQGVDVQRVVVVGLRHPVMKISHYLSRNPWVGMNMVGYFRTPYDLAVAEQRQGLPCLGDPDELIEYLKNNQVEQVWISLPLGERDHIKQLLQRLDRYPINVKLVPDLFDFGLLNQSAEQIGSVPVINLRQGGVDRDNYFVVAKALQDKILAVIALMGLWPLMLAIAVGVKMSSPGPVFFRQRRHGLGGREFYMFKFRSMRVHDDHGTTIQQATKNDTRITRFGSFLRRSSLDELPQIFNVLGGSMSIVGPRPHAAQHNTHYEKLINHYMQRHYVKPGITGWAQVNGFRGETPELRTMKKRIQYDLDYIRRWSLWLDIRIIVLTAVRVLGQKTAY	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	124.74	gnl|BL_ORD_ID|732|hsp_num:0	776		
BGC0000800.1|Xanthan_6 # 5177 # 6475 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.574	BGC0000800.1|Xanthan_6 	5177	6475	+	Loose	500	27.7202	vanWG	23.08	3002965	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	ATGCTGATTCAAATGAGCGAGCAGGCGCGGGTGCGTTGGCACAACGCGCTGATCGAGCTGACCCTGCTGACCGGCGTGGGCTACAACCTGCTGCTGGCGTTGATCAACGCCAACGTGTTCACCGTACGTCCGGTGATCACATATGCAGTGGAATTTCTGGTCTACGCAGCCTGTTTCCTGCTCGGGCTGGGCTCGATGAGCCGACAGCGCATCGCGATGATCTTCGGCGGGCTAGGCTTGATCGTGACGCTGATGTTCGTGCGTTTCCTGGTCAACTGGCAGATCGACCCCAAGTTCTTCCGCGATGCCCTGGTGGTCTTTGCATTTGTCGTGCTGGGGTCTGCTTACACCGGCTCGTTGCCCAAGCTGTTCATACGCATGACGATCATCGTGTCATTGGTCGCTGCGTTCGAGCTGGCGATGCCCTCGGCTTATGGCGATCTGGTCAACCCGAAGAGCTTCTTCGTCAATGCGCGCGGCATGAGTGCAGAAGGGTTCTGGAACGAGGACAGCAATCTGTTCGTCAGTGCCACACGACCCGGTGAGCGCAACTTCCTCCCAGGCTCGAACCTGCCACGCGCCTCTTCCTGGTTCATCGAGCCGGTGACGATGGGCAATTACATCTGCTTCTTCACCGCGATCGTATTGACGTTCTGGCGCTGGATGCGGCCGTCGATGCTGATTCTGTCTATTGGATTGATCGGCTTCATGATTGTGGCATCCGACGGCCGACTGGCTGCCGGCACCTGTGTGCTGATGGTGCTGCTGTCGCCGTTATTGAAACGGATGGATCAGCGGTTGGCGTTCCTGTTGTTCCTGTTTGTGATCGCCTCTGCCTGGCTGCTGGTGTGGATGACCGGGATTACGGCCTACCAGGACACCACGATGGGGCGCATCTTCTTCACTGTGAATTCGATGAACAATCTATCGTTCGAGTCGTGGATGGGCCTGGATTTTGCGCAGGCCTACCGGTATTTCGACAGCGGTATTTCTTACTTTATTGCTTCGCAGTCGATTGTCGGCGTGCTGGCGTTCCTGCTGTCTTATTCGTTCCTGCTGCTGATGCCGAGCAAGGAAGGGCAGTTGTTCAAAAACCAGGCGATGTTTGCCTTTGCACTGAGCCTGTTGGTGTCTAACGGCTATTTCTCGATCAAGACATCGGCGCTGTGGTGGTTTGTCTGCGGCTGCATGTGGCACCTGATGCCAGCAGCGTCAGCCGTGCCGGTGCGCGACGAAAGCAAGGAAGATCCAACGGACAACGGCGTGCATGTGCCGTTGCCCGCAGGAGCGCCGCGGTGA	MLIQMSEQARVRWHNALIELTLLTGVGYNLLLALINANVFTVRPVITYAVEFLVYAACFLLGLGSMSRQRIAMIFGGLGLIVTLMFVRFLVNWQIDPKFFRDALVVFAFVVLGSAYTGSLPKLFIRMTIIVSLVAAFELAMPSAYGDLVNPKSFFVNARGMSAEGFWNEDSNLFVSATRPGERNFLPGSNLPRASSWFIEPVTMGNYICFFTAIVLTFWRWMRPSMLILSIGLIGFMIVASDGRLAAGTCVLMVLLSPLLKRMDQRLAFLLFLFVIASAWLLVWMTGITAYQDTTMGRIFFTVNSMNNLSFESWMGLDFAQAYRYFDSGISYFIASQSIVGVLAFLLSYSFLLLMPSKEGQLFKNQAMFAFALSLLVSNGYFSIKTSALWWFVCGCMWHLMPAASAVPVRDESKEDPTDNGVHVPLPAGAPR	MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEISFDDNFMYGRILSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKLPDDVKIEERGV	153.74	gnl|BL_ORD_ID|1528|hsp_num:0	1622		
BGC0000800.1|Xanthan_7 # 6472 # 7566 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.613	BGC0000800.1|Xanthan_7 	6472	7566	+	Loose	1300	30.4166	vanTC	30.0	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGAATACGGTGACAGGGGCATCGGGGACGTCGGCGCCTGTGCAGGCTGCCGGCGCGCGTGCCTTCGCGAGCGGCCGTAGCCGCGATCCACGTATCGATGCGACCAAGGCGATCGCGATATTGCTGGTGGTGTTCTGCCACGCAAAAGGCGTGCCGCACGGAATGACCCTGTTTGCCTACAGCTTTCACGTTCCGCTTTTCTTCCTCGTGTCGGGTTGGCTGGCTGCCGGTTATGCCTCGCGCACAACCAGCCTGCTGCAGACAATCACCAAGCAGGCACGTGGTCTGTTGCTGCCCTATGTCGTGTTCTATCTGCTTGGATATGTGTATTGGCTGTTGACGCGCAACATCGGCGAGAAAGCTGCACGTTGGGGGAGCCACCCGTGGTGGGAGCCGATCGTGTCGATGTTTACCGGCGTCGGCCCGGATCTGTATGTGCAGCCGCCGCTGTGGTTCCTGCCGGTGATGCTGGTCACCGTGATTGGCTACGTTCTGTTGCGGCGCTGGATGCCGCCACTGGTCATTGCGGCTGTCGCAGTTGTTCTCGCCTGGTTCTGGATGAACTGGTTTCCGCTCCAGCACATGCGATTGTTCTGGGGCCTGGATGTGCTACCGGTGTCGCTGTGCTTCTACGCACTGGGCGCGCTGCTGATCCACGTGTCGCCGTATCTTCCAACCTCCTTGCCTGGTAGCGCGTTGGTCACCGTAGTGCTGGCAGCATTGGTTGCCTGGCTGGCCGGGGTCAACGGCCGCATCGATGTCAACATGCTGGAATTCGGAAGGCAGCATGCCGTATTCCTGTTGAGTGCAGTGGCGGGTTCGTTGATGGTGATCTGCGCGGCGCGCATGGTGCAGGAATGGACATGGCTGCAGTGGATCGGGCGCAACACCTTGCTGATCCTGTGCACGCACATGCTGGTCTTCTTTGTACTGTCTGGTGTTGCGGCCTTGGCGGGTGGGTTTGGTGGGGCGCGCCCAGGCCTTGGTTGGGCCATCTTCGTGACGCTCTTTGCGCTGGTCGCCAGCGTTCCGCTGCGCTGGTTTCTGATGCGTTTTGCCCCCTGGACCTTGGGTGCACGTCCGGTGTCGGCATGA	MNTVTGASGTSAPVQAAGARAFASGRSRDPRIDATKAIAILLVVFCHAKGVPHGMTLFAYSFHVPLFFLVSGWLAAGYASRTTSLLQTITKQARGLLLPYVVFYLLGYVYWLLTRNIGEKAARWGSHPWWEPIVSMFTGVGPDLYVQPPLWFLPVMLVTVIGYVLLRRWMPPLVIAAVAVVLAWFWMNWFPLQHMRLFWGLDVLPVSLCFYALGALLIHVSPYLPTSLPGSALVTVVLAALVAWLAGVNGRIDVNMLEFGRQHAVFLLSAVAGSLMVICAARMVQEWTWLQWIGRNTLLILCTHMLVFFVLSGVAALAGGFGGARPGLGWAIFVTLFALVASVPLRWFLMRFAPWTLGARPVSA	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	52.15	gnl|BL_ORD_ID|692|hsp_num:0	734		
BGC0000800.1|Xanthan_8 # 7563 # 8702 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.603	BGC0000800.1|Xanthan_8 	7563	8702	+	Loose	1300	28.4906	vanTG	39.29	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGACGACGGCTGCGATCACTGCCGGTCGCGTCGACACAATCGCCTCAACTGTCGCGGAGCGCGACTGGCAGATCGACGTGGCCAAGGCTCTTGCGATCATTCTGGTCGCGCTGGGGCACGCCAGTGGCATGCCGCCTGCCTACAAGCTGTTTGCCTACAGCTTCCATGTGCCTCTGTTTTTCGTTCTTTCCGGCTGGGTCGGTGAACGCTTCGGGCGTCGTGCATTTGGCCGGAAGACGGTGGGAAAGCTTGCGCGCACGCTGCTGATTCCCTACGTCAGCTTTTTTCTGGTGGCTTACGGCTACTGGATACTGAGCGCAGTGCTCAACGGCACATCCCAGTCCTGGGCTGGCCACCCCTGGTGGCATCCGTTTGTTGGATTGCTGTGGGCCAATGGATCCAGCTTGTATGTGCTCCCGGCCTTGTGGTTTCTCCCCGCACTGTTTGTCGCCACCGTTGTCTACCTGGCACTGCGCGAAGACCTGAGCGCCGCAGTGCTCGCGGTCTGCAGTTTGCTGGTTGTGTGGGCGTGGACGCGTTGGTTCCCAGGGCTGCGGCTGCGCCTTCCGTTTGCACTGGATGTGCTGCCGGTCGCGCTGTTCTTCATTGCAGTCGGCGCATGGCTGTCACGCTTCGCAGAGAGAGTGCGCGCGCTTCCTGCGGTCGTTTGGGTCGTCGCGTTCCCGGTCCTGGCATTCGCCTGGGGGGGCGTTGCAGCCATGAACGGGCAGGTGGATGTCAATAATCTTCAGTTCGGAAAATCGTCGCTCCTGTTCCTGATCGCAAGCCTGCTGGGTACAGCAATGACGTTGTGCATTGCCTACTTCATGCAAGGGTGGCGCTGGCTGCGTTGGATCGGCGCCAATACGCTGCTGATCCTTGGCACGCACACGTTGGTGTTTCTGGTCGTGACCAGTGTCGTGGTGCGAACCGGGGTGATCGATCGCAAACTCATCGGTACACCTGTCTGGGCGCTGGCTCTCTGCGCCTTTGCCATCGCTGCCTGCATTCCCATGCGTGCCGTGCTGGTGCGCCGCGCCCTGGATGTTGGGATTGAAACGCAAGTGAGACATTTTCAGAATCATCAGTCGATGTGGCGTGTTCGTGTGAGTCACCGGCAAAGGAGATCGGCGCAATGA	MTTAAITAGRVDTIASTVAERDWQIDVAKALAIILVALGHASGMPPAYKLFAYSFHVPLFFVLSGWVGERFGRRAFGRKTVGKLARTLLIPYVSFFLVAYGYWILSAVLNGTSQSWAGHPWWHPFVGLLWANGSSLYVLPALWFLPALFVATVVYLALREDLSAAVLAVCSLLVVWAWTRWFPGLRLRLPFALDVLPVALFFIAVGAWLSRFAERVRALPAVVWVVAFPVLAFAWGGVAAMNGQVDVNNLQFGKSSLLFLIASLLGTAMTLCIAYFMQGWRWLRWIGANTLLILGTHTLVFLVVTSVVVRTGVIDRKLIGTPVWALALCAFAIAACIPMRAVLVRRALDVGIETQVRHFQNHQSMWRVRVSHRQRRSAQ	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	53.23	gnl|BL_ORD_ID|1468|hsp_num:0	1561		
BGC0000800.1|Xanthan_9 # 8699 # 9841 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.619	BGC0000800.1|Xanthan_9 	8699	9841	+	Loose	800	28.4906	Chlamydia trachomatis intrinsic murA conferring resistance to fosfomycin	40.91	3003785	protein homolog model	n/a	n/a	fosfomycin	antibiotic target alteration	antibiotic-resistant murA transferase	ATGAAAGTCGTGCATGTGGTCCGCCAGTTCCATCCGTCGATCGGGGGGATGGAGGAAGTCGTGCTGAACGTGGCACGTCAGCATCAGGCCAACAGTGCCGACACGGTTGAGATCGTGACGTTGGATCGTGTGTTCACCGATCCCTCTGCGCAACTGGCGCAGCACGAGCTCCATCAGGGGTTGTCGATCACTCGCATCGGCTATCGTGGTTCATCGCGGTACCCGATCGCGCCGTCGGTGCTGGGGGCGATCCGTTCGGCGGACGTGGTGCATCTGCATGGCATTGATTTTTTCTACGACTACCTGGCGTTGACCAAGCCGCTGCACGGCAAGCCGATGGTGGTCTCGACGCATGGCGGGTTTTTCCACACTGCCTATGCGTCGCGCATGAAGCAGATCTGGTTCCAGACGCTGACGCGTACTTCTGCGCTGGCCTATGCGCGTGTGATCGCCACTAGCGAGAATGACGGCGATCTGTTCGCCAAGGTGGTCGCGCCGTCGCGCTTGCGGGTGATCGAGAACGGTGTCGACGTGGAGAAGTATGCAGGGCAGGGCGCTCGAGCGCCGGGACGGACCATGCTGTATTTCGGGCGTTGGTCGGTCAACAAGGGCCTGATCGAAACGCTTGAATTGCTGCAGGCTGCGCTCACGCGTGATCCGCAGTGGCGGTTGATCATCGCCGGGCGCGAGTACGATTTGAATGAGGCGGATCTGCGCAAGGCCATCGCCGAACGCGGTTTGCAGGACAAGGTGCAGCTGAGCATGTCGCCATCGCAGCAGCAGTTGTGCGCGTTGATGCAGCAGGCGCAGTTCTTCGTGTGCCTGTCGCGGCATGAGGGGTTTGGGATTGCGGCGGTGGAAGCGATGAGCGCGGGGTTGATCCCGATTCTCAGCGACATTCCTCCGTTCGTGCGGCTTGCCACCGAGTCCGGACAGGGTGTGATCGTCAATCGCGACAGGATTCAGGCCGCGGCCGACAGCGTGCAAGCATTGGCGCTGCAGGCCAATGCGGATTTCGATGCGCGCCGCACGGCGACCATGGCGTATGTGGCGCGCTACGACTGGCGGCACGTGGTGGGGCGTTATATCGACGAGTACCACGCTGCGCTGGGAACACCACGTACGCAGGAGGCCGTGCGATGA	MKVVHVVRQFHPSIGGMEEVVLNVARQHQANSADTVEIVTLDRVFTDPSAQLAQHELHQGLSITRIGYRGSSRYPIAPSVLGAIRSADVVHLHGIDFFYDYLALTKPLHGKPMVVSTHGGFFHTAYASRMKQIWFQTLTRTSALAYARVIATSENDGDLFAKVVAPSRLRVIENGVDVEKYAGQGARAPGRTMLYFGRWSVNKGLIETLELLQAALTRDPQWRLIIAGREYDLNEADLRKAIAERGLQDKVQLSMSPSQQQLCALMQQAQFFVCLSRHEGFGIAAVEAMSAGLIPILSDIPPFVRLATESGQGVIVNRDRIQAAADSVQALALQANADFDARRTATMAYVARYDWRHVVGRYIDEYHAALGTPRTQEAVR	MPGIKVFGETVLRGSVRVSGAKNATTKLLVASLLSDQRTILKNVPNIEDVRQTVDLCRVLGAIVEWDQQAQVIEIHTPRILLSKVPPQFSCVNRIPILLLGALLRRCPYGIFVPILGGDAIGPRTLHFHLEGWKKLGAEIVISDEGYWASAPNGLVGAHITLPYPSVGATENLILASVGAQGRTIIKNAALEVEIIDLIVFLQKAGVEITTDNDKTIEIFGCQDFYSVEHFIIPDKIEAASFGMAAVVSQGRIFVEQARHEHMIPFLKVLRSIGGGFSVHENGIEFFYDKPLKGGVLLETDVHPGFITDWQQPFAVLLSQSEGCSVIHETVHENRLGYLKGLVKMGAHCDLFHECLSAKSCRYSTGNHPHSAVIHGPTPLQATDLVIPDLRAGFAYVMAALIAEGGASWIENTEMLDRGYTDWRGKLERLGAKVLARDAVSVYV	85.59	gnl|BL_ORD_ID|2414|hsp_num:0	2291		
BGC0000800.1|Xanthan_10 # 9838 # 10887 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.651	BGC0000800.1|Xanthan_10 	9838	10887	+	Loose	600	26.5646	clbB	42.86	3002815	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGAGCGCGTCTGCTTCGCTGCCAGTGACGCGTGCTGCTGCGGCGCCCCGGATCACGGTGCTGTTCTCCACCGAAAAGCCGAACGCCAACACCAACCCGTATCTCACCCAGCTCTACGATGCGCTGCCGGACGCGGTGCAGCCGCGCTTCTTTTCGATGCGCGAGGCGTTGTTGTCGCGCTACGACGTGCTGCATCTGCACTGGCCGGAATATCTGCTGCGCCATCCCAGCAAGATGGGCACGCTGGCCAAGCAGGCCTGCGCTGCCTTGCTGCTGATGAAGTTGCAGCTGACCGGCACGCCGGTGGTACGCACCTTGCACAACCTGGCGCCGCATGAAGACCGCGGCTGGCGGGAGCGCGCGCTGCTGCGCTGGATCGATCAGCTCACGCGGCGCTGGATCCGCATCAACGCCACTACACCGGTGCGGCCGCCGTTCACCGACACCATCCTGCACGGCCATTACCGCGACTGGTTCGCGACGATGGAGCAGAGCACCACGTTGCCTGGTCGGCTGCTGCATTTTGGATTGATCCGGCCGTACAAGGGCGTTGAGGTGTTGCTCGACGTCATGCGCGGATGTGCAGGACCCGCGCCTGAGCCTGCGCATCGTCGGCAACCCGGCGACGCCAGGATGCGCACGCTGGTCGAAACCGCCTGCGCGCAGGATGCACGTATCAGTGCACTGCTGGCCTATGTCGAGGAGCCGGTGCTCGCGCGCGAAGTCAGTGCCTGCGAACTGGTGGTACTGCCATACAAGCAGATGCACAACTCCGGCACCTTGCTGCTGGCGTTGTCGTTGGCGCGGCCCGTGCTTGCGCCGTGGAGCGAATCGAACGCCGCGATCGCCGACGAAGTCGGGCCGGGTTGGGTGTTCCTGTACGAAGGCGAGTTCGATGCGGCGTTGTTGAGCGGCATGCTCGATCAGGTGCGCGCCGCGCCGCGTGGCCCGGCGCCCGATCTTTCACAACGTGATTGGCCACGGATCGGGCAATTGCACTATCGCACCTACTTGGAAGCGCTCGGCAAGGATGGAGACGCCGCGCTGTGA	MSASASLPVTRAAAAPRITVLFSTEKPNANTNPYLTQLYDALPDAVQPRFFSMREALLSRYDVLHLHWPEYLLRHPSKMGTLAKQACAALLLMKLQLTGTPVVRTLHNLAPHEDRGWRERALLRWIDQLTRRWIRINATTPVRPPFTDTILHGHYRDWFATMEQSTTLPGRLLHFGLIRPYKGVEVLLDVMRGCAGPAPEPAHRRQPGDARMRTLVETACAQDARISALLAYVEEPVLAREVSACELVVLPYKQMHNSGTLLLALSLARPVLAPWSESNAAIADEVGPGWVFLYEGEFDAALLSGMLDQVRAAPRGPAPDLSQRDWPRIGQLHYRTYLEALGKDGDAAL	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	101.75	gnl|BL_ORD_ID|112|hsp_num:0	127		
BGC0000800.1|Xanthan_11 # 10884 # 12380 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.633	BGC0000800.1|Xanthan_11 	10884	12380	+	Loose	600	26.1794	cepA	27.08	3003559	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	cepA beta-lactamase	GTGACCGCAGAGACATCGACCATGACTTCCCCAACACCGCCGCCGCGCAGCCTCGGGTCGCGTGCCGCTGGCGCCGCCGTGACCATGATCGGGCAGTCGGCCAAGATGATCGTGCAGTTCGGCGGCATCGTGCTGCTGGCACGCTTGTTGACGCCGTACGACTACGGCTTGATGGCCATGGTGACCGCCATCGTGGGGGCCGCCGAAATCCTGCGCGACTTCGGTCTCTCCGCAGCCGCCGTCCAGGCGAAACATGTCAGCCGCGAGCAACGCGACAACCTGTTCTGGATCAATAGCGGCATCGGTCTGATGCTGTCGGTGGTGGTGTTCGCCAGCGCGCACTGGATTGCGGACTTTTATCACGAGCCCGCATTGGTGACGATTTCGCAGGCATTGGCGGTGACCTTCCTGCTCAACGGGATGACCACCCAATACCGCGCACACCTCAGTCGGGGGCTGCGCTTCGGTCAGGTAGCGCTGAGCGATGTGGGTTCGCAGGTGTTGGGGTTGGGTGCTGCAGTTGCGGCCGCCTTGGCCGGCTGGGGCTACTGGGCGTTGATCGTGCAGCAGGTGGTGCAGGCCATCGTGAACCTGATTATCGCTGGCGCATGTGCACGCTGGTTGCCGCGCGGGTACGCGCGGCAGGCGCCGATGCGCGATTTCATGAGCTTTGGCTGGAACCTGATGGCGGCGCAGCTGCTCGGCTATGCGAGCCGCAACGTTGGCCAGGTGATCATCGGCTGGAGGACCGGGCCCGACGCGCTGGGTCTGTACAACCGTGCCTTCCAGTTGTTGATGATGCCGTTGAATCAGATCAATGCGCCTGCGACTAGTGTGGCGCTGCCGGTGTTGTCGCAATTGCAGGATGAGCGCGAGCGCTACAGCGCTTTTCTGTTGCGCGGCCAGACGGTCATGGTGCATTTGATCTTTGCGCTGTTCGCGTTTGCCTGTGCACTGGCCATGCCGCTCATCGTCCTGGTGCTGGGTGAGCAGTGGCGGGAAGCGGTGCCGCTGTTTCAGGTGTTGACGCTGGGCGGTATCTTCCAGACGGCGTCGTACGCAACCTACTGGGTGTTCCTGTCGAAGGGGTTGATGCGCGAGCAGTTGGTGTATTCGTTGGTCGGTCGCATCCTGCTCATCGCCTGCATTTTTGTTGGCTCCCGCTGGGGGGCCATGGGCGTGGCGATCGGCTACTCATTCGGCCTGCTGTTGATCTGGCCGCTGTCGCTGGTCTGGATCGGCAAGATCACGGACGCACCGGTCGGTGCGTTGTTCGTCAATGCCATGCGTGCGCTGGTGGCCTACGGTATCGCCGGCGGCTGCGCTTATTACGCATCGGTCACTGTCGGTGGTCCATTGTGGCAGCAGCTGCTGGTCGGCGCCGGCGCGATGGCGCTGGTCTGTCTGCTCGCATTGGCATGGCCGGGATTCCGGCGTGACGTGGTCGCTATCGTCAATATCCGCAAGCTGCTCACGCAGGCGAAGGCGCGCCGATGA	MTAETSTMTSPTPPPRSLGSRAAGAAVTMIGQSAKMIVQFGGIVLLARLLTPYDYGLMAMVTAIVGAAEILRDFGLSAAAVQAKHVSREQRDNLFWINSGIGLMLSVVVFASAHWIADFYHEPALVTISQALAVTFLLNGMTTQYRAHLSRGLRFGQVALSDVGSQVLGLGAAVAAALAGWGYWALIVQQVVQAIVNLIIAGACARWLPRGYARQAPMRDFMSFGWNLMAAQLLGYASRNVGQVIIGWRTGPDALGLYNRAFQLLMMPLNQINAPATSVALPVLSQLQDERERYSAFLLRGQTVMVHLIFALFAFACALAMPLIVLVLGEQWREAVPLFQVLTLGGIFQTASYATYWVFLSKGLMREQLVYSLVGRILLIACIFVGSRWGAMGVAIGYSFGLLLIWPLSLVWIGKITDAPVGALFVNAMRALVAYGIAGGCAYYASVTVGGPLWQQLLVGAGAMALVCLLALAWPGFRRDVVAIVNIRKLLTQAKARR	MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDIHYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIADLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNWTTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGDRNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID	166.00	gnl|BL_ORD_ID|1581|hsp_num:0	1677		
BGC0000800.1|Xanthan_12 # 12445 # 13647 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.598	BGC0000800.1|Xanthan_12 	12445	13647	+	Loose	660	29.261	MexS	27.17	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGTCTCTCCCGCAGCTCCAGCTTCCGGCATTCGCCGTCCCTGCTATCTGGTCTTGTCTGCTCACGATTTCCGCACGCCACGTCGGGCTAACATCCATTTCATCACCGATCAGTTGGCTTTGCGTGGCACGACGCGTTTTTTTTCGTTGCGATACAGCAGACTCTCCCGCATGAAGGGAGATATGCGCCTGCCGCTGGATGACACCGCAAATACCGTTGTCTCGCACAACGGTGTGGACTGTTACCTGTGGCGCACGACGGTGCATCCATTCAATACACGCCGGAGCTGGCTACGTCCTGTGGAAGACGCCATGTTCCGCTGGTATGCCGCGCATCCGCCAAAGCAGTTGCTGGACTGGATGCGCGAGTCCGATGTCATCGTGTTTGAAAGCGGGATCGCAGTCGCATTCATCGAGCTTGCCAAGCGGGTCAATCCGGCTGCCAAACTGGTCTATCGCGCGTCGGACGGGCTGAGCACCATCAACGTGGCGTCTTACATCGAGCGCGAGTTCGACCGCGTGGCTCCGACGCTGGACGTCATTGCCTTGGTGTCGCCCGCGATGGCCGCAGAAGTAGCAAGCCGCGACAACGTCTTCCATGTAGGTCACGGCGTGGACCACAACCTCGATCAGCTCGGCGACCCGTCGCCGTATGCCGAAGGCATCCATGCAGTTGCGGTCGGGTCGATGCTGTTTGATCCTGAATTTTTCGTCGTTGCCAGCAAGGCCTTTCCGCAAGTGACCTTCCACGTGATCGGCTCCGGGATGGGCCGCCATCCGGGCTACGGCGACAATGTCATTGTCTATGGCGAAATGAAGCACGCGCAGACGATTGGCTATATCAAGCACGCACGTTTCGGCATTGCGCCTTACGCGTCCGAGCAGGTGCCGGTGTATCTGGCAGACAGCTCAATGAAATTGCTGCAATACGACTTTTTCGGCTTGCCGGCGGTGTGCCCGAATGCTGTGGTGGGGCCGTACAAATCGCGCTTCGGGTACACGCCAGGCAATGCCGATTCGGTGATTGCCGCCATTACCCAGGCACTGGAAGCACCGCGTGTACGTTACCGCCAGTGTCTCAACTGGTCCGACACCACCGACCGCGTGCTCGACCCACGGGCGTACCCGGAAACCCGTCTTTATCCGCACCCCCCCACCGCCGCGCCGCAGCTCTCTTCGGAGGCAGCGCTCTCACATTGA	MSVSPAAPASGIRRPCYLVLSAHDFRTPRRANIHFITDQLALRGTTRFFSLRYSRLSRMKGDMRLPLDDTANTVVSHNGVDCYLWRTTVHPFNTRRSWLRPVEDAMFRWYAAHPPKQLLDWMRESDVIVFESGIAVAFIELAKRVNPAAKLVYRASDGLSTINVASYIEREFDRVAPTLDVIALVSPAMAAEVASRDNVFHVGHGVDHNLDQLGDPSPYAEGIHAVAVGSMLFDPEFFVVASKAFPQVTFHVIGSGMGRHPGYGDNVIVYGEMKHAQTIGYIKHARFGIAPYASEQVPVYLADSSMKLLQYDFFGLPAVCPNAVVGPYKSRFGYTPGNADSVIAAITQALEAPRVRYRQCLNWSDTTDRVLDPRAYPETRLYPHPPTAAPQLSSEAALSH	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	117.99	gnl|BL_ORD_ID|1067|hsp_num:0	1041		
BGC0000800.1|Xanthan_13 # 13689 # 14483 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.599	BGC0000800.1|Xanthan_13 	13689	14483	+	Loose	1200	26.1794	tetB(P)	48.0	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGCCAACGCTTTACTGCAGAAATGGGTGGAACGGGCGGAACGTCGCGCATTGTTCTGGTGGCAGCCCAAAAACGGTGGCGTGAACATGGGGGATCACCTGTCGAAGGTGATCGTGTCGTGCGTGTTGGCGTTGCAGGACAAGACACTTCTGGAAAAACGCGATTTGCGCCAGAAGCTGATCGCAACCGGGTCGGTGCTGCATTTCGCCAAAGATGGCGACACCGTGTGGGGAAGCGGTATCAACGGCAAGATTCCGGCCGAGCGCAATACGTTCAGCACGCTGGACGTACGCGCGGTACGCGGTCCCAAGACCCGCGCATTTTTGCTGGAACGTGGCATCGCAGTGCCTGAGGTCTACGGAGACCCGGGATTGCTGACCCCGATGTTTTTCCCCGCCGACGCCCTCGGCCCGGTCACCAAGCGCCCGTTCGCGATCGTGCCGCACTTCAACGAGCCGGTTGAGAAGTACAGCGCCTACGCCGAGCATCTGGTGTTTCCCAACGTCAAGCCGGCCACCTTCATGAGTGCGCTGCTGGGTGCGGAATTTGTCATCAGCAGTTCGCTGCATGGCCTGATCCTGGCCGAAGCCTATGGCATCCCGGCGGTGTATCTGGACTGGGGCAACGGCGAAGACCGTTTCAAGTACGACGACTACTACCACGGCACCGGGCGCATGCAATGGCATGCCGGCCACAGCGTGGAAGAATGCATGGAACTGGGCGGCAACGGCAGTTTCGATCTTGAACGCTTGCAGGCAGGATTGCTGGCTGCGTTCCCTTACGATTTGTGGTGA	MANALLQKWVERAERRALFWWQPKNGGVNMGDHLSKVIVSCVLALQDKTLLEKRDLRQKLIATGSVLHFAKDGDTVWGSGINGKIPAERNTFSTLDVRAVRGPKTRAFLLERGIAVPEVYGDPGLLTPMFFPADALGPVTKRPFAIVPHFNEPVEKYSAYAEHLVFPNVKPATFMSALLGAEFVISSSLHGLILAEAYGIPAVYLDWGNGEDRFKYDDYYHGTGRMQWHAGHSVEECMELGGNGSFDLERLQAGLLAAFPYDLW	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	40.49	gnl|BL_ORD_ID|758|hsp_num:0	804		
BGC0000800.1|Xanthan_14 # 14527 # 15282 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.673	BGC0000800.1|Xanthan_14 	14527	15282	+	Loose	1300	26.9498	vanTC	24.0	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGAGTGCAGCGACACCTGCGCAAGGGGTGGTGATTCCGCTGGGCGGCTTCCCGGTGTTGTCGACCACGCAGGAAGCCTTCGCGCTGGATCTGTTCCATGCGCTGGCCGCGCATCAGCCGCGCCGGGTGTTTTTCGCGAACACCAACTTCATCGTGCAGTGCCAGGCGCTGCGCGCGCGCATGCAGGCGCCGGCAGTGCGCATCGTCAACGATGGGATCGGCATGGATCTGGCGGCGCGCCTGATCCATGGCCGCCGGTTCGCCGGCAACCTCAACGGCACCGACCTGATTCCGTACCTTTGCCGCGAGGCCGCGCAGCCGCTCAAGTTCTTCCTGCTCGGCGGCCGCCCGGGCGTGGGCAAGACCGCCGCGGCGACCTTGACCGGAACGCTGGGCCAGCAGGTCGTGGGCATGTGCGATGGGTATGGCGAATTTGCGGCGGCGGGCGAGGGCCTGGCCGAGCGCATCAATCGCTCCGGCGCCGATGTGCTGTTGGTGGCCTTCGGCAACCCGCTGCAGGAGCGGTGGATCCTGGACCACAGCGAGGCCTTGCAGGTGCCGCTGGTGTTCGGCGTGGGCGCCTTGCTGGATTTTCTCTCCGGCACTGCCAAGCGCGCGCCCAACTGGGTGCGCCGTTTGCATATGGAATGGATGTACCGGCTGCTCAACGAGCCGCGCCGGTTGCTCAAGCGCTACAGCTGGGATCTGCTGGTGTTCTTCCGCACCTGCCTGCGTGCGGGCAAACAGCTGGCGTGA	MSAATPAQGVVIPLGGFPVLSTTQEAFALDLFHALAAHQPRRVFFANTNFIVQCQALRARMQAPAVRIVNDGIGMDLAARLIHGRRFAGNLNGTDLIPYLCREAAQPLKFFLLGGRPGVGKTAAATLTGTLGQQVVGMCDGYGEFAAAGEGLAERINRSGADVLLVAFGNPLQERWILDHSEALQVPLVFGVGALLDFLSGTAKRAPNWVRRLHMEWMYRLLNEPRRLLKRYSWDLLVFFRTCLRAGKQLA	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	35.96	gnl|BL_ORD_ID|692|hsp_num:0	734		
BGC0000800.1|Xanthan_16 # 15871 # 16074 # 1 # ID=1_16;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.696	BGC0000800.1|Xanthan_16 	15871	16074	+	Loose	400	22.7126	VIM-17	34.04	3002287	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGCAGCGCAGGGGGGCGGTGTGGCGGGCAGGAATCGCGTTGGTGTCGTTGTTGGCACCGATGCTGGCGTGTGCCGTCGAGGTGGCCGTACAGGCGCCGGCAGCGCCGCCAACGGTGGTCGATCTGGAAGCCATGGTGGTGCGCGGGCAGCAACCCGGCCCCGGCCTGTGGAAGGTCAGCAAGGGCGACCACGTGCTGTGGATC	MQRRGAVWRAGIALVSLLAPMLACAVEVAVQAPAAPPTVVDLEAMVVRGQQPGPGLWKVSKGDHVLWI	MFKLLSKLLVYLTASMMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGHGLPGGLDLLKHTTNVVKAHTNRSVVE	25.56	gnl|BL_ORD_ID|155|hsp_num:0	168		
